Full history for every metric is available with a Kvantra account

Stock profile

Opsens Inc. (OPS.TO)

Country: CanadaSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: TSX

Delisted · last close 13 Dec 2023

Current price
2.90 CAD0.00%
Last close 13 Dec 2023
Benchmarks

Key financial summary

Financials in CAD
201820192020202120222023TTM
Total revenueCAD m24332934354848
Operating profitCAD m-12-12
Net profitCAD m-5-2-5-1-11-12-12
EPS reportedCAD-0.11-0.11
Operating cashflow per shareCAD-0.13-0.13
Capex per shareCAD0.020.02
FCF per shareCAD-0.15-0.15
Free cash flowCAD m-17-17
Net debtCAD m-9-16
Book value equityCAD m3434
Book value per shareCAD0.290.29
Number of sharesm115.22115.22
DPS (TTM paid)CAD0.000.00

Financial summary

Financials in CAD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx6.819.90
P/S LTMx4.776.93
P/FCF LTMx-13.55-19.70
EV/EBITDA LTMx-22.77-32.51
EV/Sales LTMx4.586.59
Earnings Yield LTM%-5.38%-3.72%
FCF Yield%-7.38%-5.08%
Quality
ROE%-36.66%-36.43%
ROIC%-27.49%-27.49%
Operating margin%-24.47%-24.47%
Gross margin%57.86%57.86%
FCF/Sales%-35.17%-35.17%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+36.87%+36.87%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-1.85-1.85
Net Debt/EBITDAx0.910.91
EBIT/Net interestx-16.40-16.40
Net debt/market cap%-3.86%-4.86%
Net debt/Equityx-0.26-0.48
Gross debt/equityx0.270.27

Company overview

Headquartered in Québec, Canada, Opsens Inc. specializes in the design, manufacturing, installation, and sale of advanced fiber optic sensors. These sensors find diverse applications in areas such as interventional cardiology, particularly for fractional flow reserve (FFR) assessment, the oil and gas industry, and various other industrial settings. The company's operations are divided into two main segments: Medical and Industrial. The Medical segment focuses primarily on physiological measurement, including FFR and dPR technologies used in the coronary artery stenosis market. It also supplies compact optical sensors for precise pressure and temperature monitoring, often integrated into other medical devices, and offers licensing for its optical sensor technology. Conversely, the Industrial segment is dedicated to creating, producing, and implementing fiber optic sensing solutions tailored for a broad spectrum of industrial applications. Opsens' product offerings include the OptoWire, an innovative optical-based pressure guidewire designed to improve clinical outcomes for patients with coronary artery disease, and the OptoMonitor system. Furthermore, the company provides a comprehensive range of fiber optic sensors for temperature, pressure, strain, displacement, and extensometry, alongside signal conditioners and OEM boards. Serving a wide array of markets, including life sciences, energy, defense and aerospace, geotechnical and civil engineering, and scientific laboratories, Opsens distributes its products globally through both a direct sales force and an established network of distributors across the United States, Japan, Canada, and other international territories.

WebsiteN/A
IndustryMedical - Instruments & Supplies
CountryCanada
Trades inCAD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 13 Dec 2023

Opsens Inc. (OPS.TO)

OPS.TO · TSX · Healthcare
2.90 CAD0.00%
Benchmarks
Financialsin CAD
20222023TTM
About

Headquartered in Québec, Canada, Opsens Inc. specializes in the design, manufacturing, installation, and sale of advanced fiber optic sensors. These sensors find diverse applications in areas such as interventional cardiology, particularly for fractional flow reserve (FFR) assessment, the oil and gas industry, and various other industrial settings. The company's operations are divided into two main segments: Medical and Industrial. The Medical segment focuses primarily on physiological measurement, including FFR and dPR technologies used in the coronary artery stenosis market. It also supplies compact optical sensors for precise pressure and temperature monitoring, often integrated into other medical devices, and offers licensing for its optical sensor technology. Conversely, the Industrial segment is dedicated to creating, producing, and implementing fiber optic sensing solutions tailored for a broad spectrum of industrial applications. Opsens' product offerings include the OptoWire, an innovative optical-based pressure guidewire designed to improve clinical outcomes for patients with coronary artery disease, and the OptoMonitor system. Furthermore, the company provides a comprehensive range of fiber optic sensors for temperature, pressure, strain, displacement, and extensometry, alongside signal conditioners and OEM boards. Serving a wide array of markets, including life sciences, energy, defense and aerospace, geotechnical and civil engineering, and scientific laboratories, Opsens distributes its products globally through both a direct sales force and an established network of distributors across the United States, Japan, Canada, and other international territories.

IndustryMedical - Instruments & Supplies
CountryCanada
Trades inCAD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free